Boston Scientific (BSX) insider buying
14 open-market purchases of BSX by Boston Scientific's executives and directors since November 2025, worth $0 in total, from SEC Form 4 filings.
The most recent: Ro Khanna bought — on March 30, 2026.
The biggest buyer over the period is Ro Khanna: 6 purchases, $0.
By year
| Year | Purchases | Value |
|---|---|---|
| 2026 | 10 | $0 |
| 2025 | 4 | $0 |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Ro Khanna | 6 | $0 |
| Gilbert Ray Cisneros, Jr. | 6 | $0 |
| Markwayne Mullin | 2 | $0 |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Mar 30, 2026 | Ro Khanna |
0 | $62.90 | — | — |
| Mar 30, 2026 | Ro Khanna |
0 | $62.90 | — | — |
| Feb 17, 2026 | Ro Khanna |
0 | $76.25 | — | — |
| Feb 17, 2026 | Ro Khanna |
0 | $76.25 | — | — |
| Feb 10, 2026 | Gilbert Ray Cisneros, Jr. |
0 | $74.26 | — | — |
| Feb 10, 2026 | Gilbert Ray Cisneros, Jr. |
0 | $74.26 | — | — |
| Jan 30, 2026 | Gilbert Ray Cisneros, Jr. |
0 | $93.58 | — | — |
| Jan 30, 2026 | Gilbert Ray Cisneros, Jr. |
0 | $93.58 | — | — |
| Jan 29, 2026 | Ro Khanna |
0 | $92.26 | — | — |
| Jan 29, 2026 | Ro Khanna |
0 | $92.26 | — | — |
| Dec 29, 2025 | Markwayne Mullin |
0 | $95.74 | — | — |
| Dec 29, 2025 | Markwayne Mullin |
0 | $95.74 | — | — |
| Nov 18, 2025 | Gilbert Ray Cisneros, Jr. |
0 | $99.23 | — | — |
| Nov 18, 2025 | Gilbert Ray Cisneros, Jr. |
0 | $99.23 | — | — |
Questions
Are Boston Scientific insiders buying the stock?
14 open-market purchases of BSX by Boston Scientific's executives and directors since November 2025, worth $0 in total, from SEC Form 4 filings. The most recent: Ro Khanna bought — on March 30, 2026.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From Boston Scientific's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.